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1. Introduction 
The irreversible damage inflicted by lasting anoxia 
to the myocardium has been ascribed [ l] to a deple- 
tion of the ATP pool below the concentration that is 
essential for the structural and functional integrity of 
the cells. It was proposed [2] that lack of ATP might 
shift the delicate balance which exists between the 
synthesis and the breakdown of proteins in the heart 
tissue in the favour of the latter and may thus be one 
of the underlying causes for the irreversible damage. 
In the isolated, perfused heart the damage caused by 
anoxia was prevented [3] by including glucose into 
the perfusion medium. This beneficial effect of glu- 
cose was attributed to the maintenance of the ATP 
concentration in the cells. Cultured heart muscle cells 
were used to investigate the eiCfect of glucose on pro- 
tein synthesis [4]. Since glucose was found to stimu- 
late protein synthesis in the anaerobic heart cells also 
under conditions when it caused no rise in the ATP 
concentration level, we suggested that in addition to 
ATP generation also some other factors must be 
involved in the ‘glucose-effect’. In cell free extracts 
certain phosphorylated sugars stimulated the initia- 
tion and elongation of the polypeptide chain [s-8]. 
Prompted by these findings we have investigated 
whether products formed from glucose through the 
glycolytic pathway and/or the pentose phosphate 
pathway (PPP) could be responsible for the glucose- 
effect observed in anaerobic heart muscle cells. The 
results indicate the involvement of the PPP in the 
glucose-dependent stimulation of protein synthesis. 
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2. Materials and methods 
2.1. Preparation of cultured cells and assay conditions 
Heart cells obtained from 3-day-old newborn rats 
(Wistar strain) were cultured in Petri dishes according 
to [9] with the modifications in [4]. 3-Day-old cul- 
tures were used for the assay of protein synthesis and 
various metabolic activities. The assay conditions and 
the assay media were as in [4] except that KCN was 
used to inhibit the respiration of the cells. Under the 
nitrogen atmosphere used previously for this purpose, 
traces of oxygen (detected by release of 14C02 from 
[6-14C]glucose) unavoidably infdtrated the system 
during incubation. This was undesirable, since we 
intended to study specifically the effect of the interme- 
diates formed in glycolysis and the PPP on protein syn- 
thesis. A rather high concentration of KCN (3-5 mM) 
was found to be necessary to suppress side effects of 
oxygen, such as the ‘Pasteur effect’ [lo]. 
2.2. Determination of glycolytic products, A TP and 
pentose phosphate pathway activity 
Glucose uptake and lactate plus pyruvate produc- 
tion by the cells were determined according to [ 11 ,121 
by adding [U-14C]glucose (1.5 X 10’ cpm/pmol) to 
the assay medium, separating by paper chromatog- 
raphy the labelled glucose from the products formed, 
and assessing the distribution of radioactivity on the 
chromatogram. In the HC104soluble fraction of the 
cells glucose 6-phosphate (G-6-P) was determined 
according to [ 131; fructose 1,6diphosphate (F-l ,6diP) 
by a modification of [ 141 and ATP according to [IS]. 
The amount of 14C02 released during the incubation 
of the cells with [ 1 -‘4C]glucose (4.0 X 10’ cpm/pmol) 
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was determined according to [ 161 and it served as a 
measure for the activity of the pentose phosphate 
pathway. 
2.3. Estimation of the rate of protein synthesis, 
counting of radioactivity, protein determination; 
materials 
All these estimations were performed as in [4]. 
Radioactive materials and other chemicals were pur- 
chased from the sources in [4]. 
3. Results 
According to [ 171 the activity of the PPP is con- 
trolled by the availability of NADP+ and hence by 
the rate of reoxidation of NADPH. The latter rate 
will be necessarily limited when respiration is sup- 
pressed. There are several ways known, however, to 
stimulate the reoxidation of NADPH. In case that the 
PPP is either directly or indirectly involved in the 
regulation of protein synthesis one could expect that 
stimulation of the PPP in non-respiring, glycolyzing 
heart muscle cells will also enhance the rate of pro- 
tein synthesis. This assumption was put to a test: In 
erythrocytes low concentrations of the auto-oxidiz- 
able dye, methylene blue, was reported to stimulate 
the PPP activity [ 181. Under the conditions used for 
the assay of the PPP-activity and protein synthesis 
in cultured heart muscle cells, however, this dye did 
not produce reproducible results. Therefore, its use 
was abandoned. Pyruvate was shown to stimulate 
strikingly the PPP activity in erythrocytes and in cer- 
tain types of tumor cells [ 19-2 11. This stimulation 
was shown to be due to transfer of reducing equiv- 
alents from NADPH to pyruvate by lactate dehydro- 
genase (LDH, EC 1 .l .1.27) which possessed sufficient 
affinity for NADPH to account for the observed 
stimulation of the PPP-activity. In heart- or skeletal 
muscle homogenates an acceleration of the PPP 
resulted from the addition of ribose-5-phosphate 
(R-5-P) to the system [22]. Also in this case, stimula- 
tion of NADPH oxidation was found to be the under- 
lying cause for the effect. The mechanism suggested 
involves the formation of glyceraldehyde 3-phosphate 
from R-5-P through the PPP and reduction of the 
former compound catalyzed by the NADPH-dependent 
glyceraldehyde 3-phosphate dehydrogenase. When 
pyruvate was added to the respiration-inhibited, 
glycolyzing, heart muscle cells, then, like in eryth- 
rocytes or tumor cells, the PPP-activity significantly 
increased (table 1). Since R-5-P does not permeate 
the plasma membrane we tested the effect of ribose 
and found that it stimulated the PPP-activity, pos- 
sibly after conversion to R-5-P. Ribose is well known 
to be metabolized by the heart muscle tissue [23]. 
Another important point which emerged from the 
experiments shown in table 1 was that though both 
the above two substances increased the rate of pro- 
tein synthesis pyruvate strongly inhibited, whereas 
ribose moderately stimulated the glycolysis. Thus, 
apparently the rate of the PPP rather than that of the 
glycolytic flux is limiting the protein synthesis. The 
experiment in table 2 was conducted to find out 
whether pyruvate or ribose by themself would affect 
protein synthesis. It can be seeri from table 2 that 
in presence of 5 mM KCN the omission of glucose 
caused severe depletion in the ATP content of the 
cells but this could be prevented by reducing the 
respiratory inhibitor to 1 mM. However, neither 
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Table 1 
Effect of pyruvate and ribose on glycolysis, PPP-activity and glucosedependent stimulation of’ 
protein synthesis 
Additions Glucose Lactate and pyr- ATPC [14C]C0,c~d [‘H]Leucine 
consumeda uvate producedatb incorpn.c 
None 0.9 1.8 16.1 5.0 1.8 
Pyruvate (5 mM) 0.4 0.7 18.0 9.0 4.0 
Ribose (SO mM) 1.2 2.4 17.0 10.0 3.3 
a pmol/mg protein; b the chromatographic method id not separate the two labelled products; ’ nmol/ 
mg protein; d released from [ l-14C]glucose 
Cells were incubated for 30 min at 37°C as in section 2. The standard medium of incubation contained 
glucose (5 mM) and KCN (5 mM). Other additions were as indicated. The data given are representative 
values: Each experiment was repeated at least 5 times 
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Table 2 
Effect of pyruvate and ribose on protein synthesis in the 
absence of glucose 
Additions KCN 
(mM) 
ATPa 
None 5.0 3.2 0.4 
Pyruvate 5.0 3.7 0.4 
1.0 15.0 0.4 
Ribose 5.0 4.5 0.5 
1.0 17.0 0.5 
a nmol/mg protein 
Glucose was omitted from the standard medium of incuba- 
tion. Other additions were as indicated. Conditions of the 
experiment were as in table 1. 
pyruvate nor ribose affected the rate or protein sy?- 
thesis in the absence of glucose - not even when suf- 
ficient ATP was generated by the residual respiratory 
activity. 
The causal relation between the activity of the PPP 
and the rate of protein synthesis was also indicated 
by the finding (fig.l) that both of the above param- 
PYRUVATE (mh4) 
Fig.1. Protein synthesis and PPPactivity as a function of the 
pyruvate concentration. Conditions of incubation as in table 1 
with 5 mM glucose added to the medium: (0) 14C0, release 
from [l-14C]glucose; (0) [3H]leucine incorporation. 
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Fig.2. Kinetics of protein synthesis and PPPactivity in the 
presence and absence of pyruvate (5 mM). Conditions of 
incubation as in fig.1. (0~8) [ 3H]Leucine incorporation; (a,~) 
“‘CO, release from [ 1-Wlglucose; open symbois, no pyr- 
uvate added; shaded symbols, with 5 mM pyruvate added. 
eters were affected in a similar manner by variations 
in the pyruvate concentration. Moreover, also the 
time-course of 14C02 release from [ 1 -‘4C]glucose and 
that of the incorporation of t3H]leucine showed 
remarkable similarity (fig.2). 
Though apparently it is not related to protein syn- 
thesis, we attempted to locate the step(s) in glycolysis 
which were affected by added pyruvate. Refering to 
the techniques used (see section 2) to separate the 
products of glycolysis, dilution of the labelled prod- 
ucts by the added unlabelled pyruvate could not 
account for the inhibition, since pyruvate and lactate 
were not separated Gn the chromatogram. Moreover, 
also the uptake of glucose was inhibited. Heart mus- 
cle LDH is known to be inhibited by pyruvate [24]. 
In~bition of LDH would limit the regeneration of 
NAD’ and thus also the activity of glyceraldehyde 
3-phosphate dehydrogenase. The resulting pattern 
would be similar to that obtained by inhibiting the 
latter enzyme with iodoacetate: i.e., accumulation of 
F-l ,6-diP would be expected to occur. However. as 
seen from table 3 in contrast to iodoacetate the addi- 
22 
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Table 3 
Effect of pyruvate and/or iodoacetate on the concentration 
of the glycolytic intermediates 
Additions G_6_pa,b F-l ,6diPa,c 
Glucose 2.6 13.3 
+ pyruvate 1.3 1.6 
+ iodoacetate 1.8 24.0 
+ iodoacetate 
f pyruvate 2.2 23.0 
a nmol/mg protein; b glucose 6-phosphate; c fructose-l ,6- 
diphosphate 
Glucose (5 mM) and KCN (5 mM) were added to the stan- 
dard medium of incubation. When indicated pyruvate (5 mM) 
and/or iodoacetate (5 PM) were also added. Conditions were 
otherwise as in table 1 
tion of pyruvate reduced the intracellular concentra- 
tion of F-l ,6-dip. Since in presence of pyruvate also 
the concentration of G-6-P was lowered it is reason- 
able to assume that pyruvate inhibited the transport 
of glucose or its conversion to G-6-P by hexokinase, 
rather than the LDH. 
4. Discussion 
The most important point emerging from this 
work is the demonstration of a certain interrelation 
in the cultured heart muscle cells between protein 
synthesis and PPP-activity. This finding suggests that 
a product of the PPP might be involved in the regula- 
tion of protein synthesis. The role of phosphorylated 
sugars in the regulation of protein synthesis has been 
implicated in the restoration of protein synthesis to 
lysates prepared from glucose-starved-reticulocytes 
[5], and also to lysates in which protein synthesis was 
impaired by heme deficiency or by adding oxidized 
glutathion [7]. The stimulatory effect of phospho- 
rylated sugars was also demonstrated in a variety of 
other mammalian cells [8]. At this stage of investiga- 
tion it is not possible to pinpoint the product of the 
PPP to which the observed effects could be ascribed. 
It may be relevant in this context to recall that 
ribose, which after being converted to R-S-P, is 
expected to produce the intermediates of the PPP, 
was not able in the absence of glucose to stimulate 
protein synthesis, just as pyruvate was not able to 
do so. Thus, the common denominator between the 
effect of pyruvate and ribose is plausibly the facilita- 
tion of the reoxidation of NADPH produced in the 
first two steps of the PPP. Therefore, either the regu- 
lation of the balance between NADPH and NADP’ is 
of importance for some step in protein synthesis or 
alternatively the concerted action of a glycolytic 
intermediate (e.g., G-6-P) and of a PPP-intermediate 
is involved in the ‘glucose effect’. 
With regard to the possible physiological implica- 
tions of these findings it is noted that according to [25] 
during the period of recovery from experimentally 
induced heart infarct not only the rate of protein syn- 
thesis was increased in the vicinity of the damaged site 
but also PPP-activity was found to be enhanced up to 
30-fold. The latter activity returned to its normal level 
after healing of the damaged tissues. It is tempting to 
speculate about the possibility that the above intimate 
connection between PPP-activity and tissue regenera- 
tion is not restricted to heart infarct. Activation of 
the PPP might more generally accompany events in 
which accelerated cell growth necessitates an incre- 
ment in the rate of protein synthesis. 
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